1. Home
  2. PBM vs SILO Comparison

PBM vs SILO Comparison

Compare PBM & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • SILO
  • Stock Information
  • Founded
  • PBM 1994
  • SILO 2010
  • Country
  • PBM Canada
  • SILO United States
  • Employees
  • PBM N/A
  • SILO N/A
  • Industry
  • PBM
  • SILO Apparel
  • Sector
  • PBM
  • SILO Consumer Discretionary
  • Exchange
  • PBM NYSE
  • SILO Nasdaq
  • Market Cap
  • PBM 5.3M
  • SILO 8.8M
  • IPO Year
  • PBM N/A
  • SILO N/A
  • Fundamental
  • Price
  • PBM $1.27
  • SILO $1.59
  • Analyst Decision
  • PBM
  • SILO
  • Analyst Count
  • PBM 0
  • SILO 0
  • Target Price
  • PBM N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • PBM 526.0K
  • SILO 805.4K
  • Earning Date
  • PBM 02-02-2025
  • SILO 02-18-2025
  • Dividend Yield
  • PBM N/A
  • SILO N/A
  • EPS Growth
  • PBM N/A
  • SILO N/A
  • EPS
  • PBM N/A
  • SILO N/A
  • Revenue
  • PBM N/A
  • SILO $72,102.00
  • Revenue This Year
  • PBM N/A
  • SILO $1.86
  • Revenue Next Year
  • PBM N/A
  • SILO N/A
  • P/E Ratio
  • PBM N/A
  • SILO N/A
  • Revenue Growth
  • PBM N/A
  • SILO N/A
  • 52 Week Low
  • PBM $1.21
  • SILO $0.77
  • 52 Week High
  • PBM $323.25
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • PBM 37.76
  • SILO 52.57
  • Support Level
  • PBM $1.21
  • SILO $1.56
  • Resistance Level
  • PBM $1.59
  • SILO $1.89
  • Average True Range (ATR)
  • PBM 0.24
  • SILO 0.19
  • MACD
  • PBM 0.03
  • SILO -0.05
  • Stochastic Oscillator
  • PBM 17.53
  • SILO 27.12

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: